Keyphrases
2 Receptor
16%
2-Arachidonoylglycerol (2-AG)
16%
Acoustic Startle Reflex
16%
AM251
16%
Basolateral Amygdala
66%
Cannabinoid Therapy
16%
CB1 Receptor
50%
CB1 Receptor Antagonist
16%
Chronic Treatment
100%
Defining Characteristic
16%
Endocannabinoid System
16%
Fatty Acid Amide Hydrolase
16%
Fatty Acid Amide Hydrolase Inhibitors
33%
Fear Extinction
16%
Hydrolase Activity
16%
N-arachidonoylethanolamine
16%
Novel Therapeutics
16%
Post-stress
100%
PTSD Symptom Clusters
16%
Rat Model
100%
Receptor Agonist
16%
Shock
83%
Startle Response
33%
Stress Symptoms
100%
Therapeutic Effect
16%
Therapeutic Strategies
16%
URB597
100%
WIN55,212-2
66%
Pharmacology, Toxicology and Pharmaceutical Science
2-Arachidonoylglycerol
16%
AM251
16%
Cannabinoid
16%
Cannabinoid 1 Receptor
50%
Cannabinoid 1 Receptor Antagonist
16%
Disease
16%
Endocannabinoid System
16%
Fatty Acid Amidase
16%
Fatty Acid Amidase Inhibitor
33%
Posttraumatic Stress Disorder
100%
Rat Model
100%
Receptor Agonist
16%
Symptom
100%
Therapeutic Effect
16%
URB597
100%
Neuroscience
2-Arachidonoylglycerol
16%
AM251
16%
Basolateral Amygdala
66%
Cannabinoid
16%
Cannabinoid 1 Receptor
50%
CB1 Receptor Antagonists
16%
Endocannabinoid System
16%
Fatty Acid Amidase
50%
Hydrolase Inhibitor
33%
Posttraumatic Stress Disorder
100%
Receptor Agonists
16%
Startle Response
50%
URB597
100%